S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.22 (-2.88%)
AAPL   122.04 (-2.46%)
MSFT   227.45 (-2.75%)
FB   255.41 (-1.39%)
GOOGL   2,011.39 (-2.57%)
TSLA   652.00 (-5.02%)
AMZN   3,005.20 (-2.89%)
NVDA   512.28 (-4.47%)
BABA   236.27 (+0.79%)
CGC   33.26 (-5.65%)
GE   13.46 (+3.70%)
MU   88.88 (-2.43%)
NIO   41.87 (-3.28%)
AMD   81.10 (-3.60%)
T   28.72 (+1.77%)
F   12.18 (-2.95%)
ACB   10.47 (-5.08%)
DIS   190.88 (-1.58%)
BA   228.45 (+2.38%)
NFLX   521.70 (-4.77%)
PFE   34.37 (+2.57%)
Log in
NASDAQ:CHRS

Coherus BioSciences Earnings Date, Estimates & History

$15.42
-0.31 (-1.97 %)
(As of 03/3/2021 03:59 PM ET)
Add
Compare
Today's Range
$15.31
Now: $15.42▼
$16.02
50-Day Range
$15.25
MA: $17.88▼
$21.39
52-Week Range
$10.86
Now: $15.42▼
$22.22
Volume45,986 shs
Average Volume1.52 million shs
Market Capitalization$1.12 billion
P/E Ratio7.56
Dividend YieldN/A
Beta1.57

Earnings

Coherus BioSciences (NASDAQ:CHRS) Earnings Information

Coherus BioSciences last posted its quarterly earnings data on February 23rd, 2021. The biotechnology company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.25 by $0.13. Coherus BioSciences has generated $1.23 earnings per share over the last year and currently has a price-to-earnings ratio of 7.6. Coherus BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.

Coherus BioSciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Coherus BioSciences (NASDAQ:CHRS) Earnings Estimates

Current Year EPS Consensus Estimate: $1.71 EPS
Next Year EPS Consensus Estimate: $0.88 EPS

Coherus BioSciences (NASDAQ CHRS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/6/2021
(Estimated)		       
2/23/202112/31/2020$0.25$0.12$0.12Transcript
11/5/20209/30/2020$0.34$0.33$0.33$120.50 million$113.55 millionListen
8/6/20206/30/2020$0.26$0.70$0.70$100.33 million$135.67 millionTranscript
5/7/20203/31/2020$0.44$0.54$0.60$116.25 million$116.18 millionTranscript
2/27/202012/31/2019$0.68$0.56$0.53$123.60 million$123.86 millionTranscript
11/6/2019Q3$0.36$0.63$0.63$93.58 million$111.68 millionTranscript
8/1/2019Q2 2019($0.08)$0.32$0.32$81.05 million$83.43 millionN/A
5/9/20193/31/2019($0.45)($0.29)($0.29)$36.83 million$37.10 millionN/A
2/28/2019Q4 2018($0.82)($0.92)($0.92)N/A
11/8/20189/30/2018($0.79)($0.87)($0.87)Transcript
8/8/2018Q2 2018($0.64)($0.68)($0.68)N/A
5/10/2018Q1 2018($0.6980)($0.74)($0.74)N/A
3/8/2018Q4 2017($0.8620)($0.84)($0.84)Transcript
11/6/2017Q3 2017($0.8320)($1.09)($1.09)N/A
8/7/2017Q2 2017($1.29)($1.08)($1.08)$1.40 millionListen
5/8/2017Q1 2017($1.54)($1.54)($1.54)$0.16 millionListen
3/13/2017Q4 2016($1.11)($1.71)($1.71)$10.00 million$0.84 millionListen
11/9/2016Q3 2016($1.5620)$1.67$1.67$7.20 million$162.80 millionListen
8/9/2016Q2($1.32)($1.72)($1.72)$6.87 million$14.07 millionListen
5/9/2016Q1($1.42)($1.67)($1.67)$12.36 millionListen
2/29/2016Q4($1.74)($1.35)($1.35)$8.63 million$10.20 millionListen
11/9/2015Q3($1.86)($1.86)$16.10 million$7.20 millionListen
8/10/2015Q215($1.56)($1.56)$488.15 million$6.87 millionListen
5/11/2015Q115($1.22)($1.22)$488.15 million$5.81 millionListen
3/23/2015Q414($0.46)($1.47)($1.47)$6.50 millionListen
12/15/2014Q212($1.79)($1.79)$16.10 millionN/A
3/27/2012($0.02)($0.06)N/A
12/1/2011($0.09)($0.08)N/A
9/1/2011$0.01($0.01)N/A
6/2/2011$0.12$0.17Transcript
3/24/2011($0.19)($0.08)Transcript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/3/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.